Pfizer (PFE)

37.28 +0.73 (2.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (1/29/20 *Est.)
- M&A (6/30/20 *Est)

Latest Headlines

Bristol-Myers Squibb and Pfizer Announce Randomized, Controlled Trial to Evaluate the Effect of Atrial Fibrillation Screening on Health Outcomes in Older Individuals November 15, 2019 9:00 AM - BizWire Trade deal hopes, surging health stocks power Wall Street to highs November 15, 2019 7:56 AM - StreetInsider Endo (ENDP) Wins Ruling to Block Generic Form of Adrenalin, Pfizer (PFE) Hospira Loses Challenge to Patents on Allergy Drug - Bloomberg November 14, 2019 10:33 AM - StreetInsider Abbott CEO Miles White to step down next year November 13, 2019 7:59 AM - StreetInsider CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc. November 13, 2019 3:24 AM - StreetInsider CENTOGENE Signs Data Access and Collaboration Agreement with Pfizer Inc. November 13, 2019 3:22 AM - Globe NewsWire Form 425 PFIZER INC Filed by: PFIZER INC November 12, 2019 4:52 PM - SEC Filing Mylan (MYL), Pfizer (PFE) Said New Company to Be Named 'Viatris' November 12, 2019 12:17 PM - StreetInsider Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination November 12, 2019 12:15 PM - PR NewsWire Mylan and Pfizer Announce Viatris as the New Company Name in the Planned Mylan-Upjohn Combination November 12, 2019 12:15 PM - BizWire Pfizer (PFE) Reports Results of Phase 3 Study for XELJANZ (tofacitinib) in Juvenile Idiopathic Arthritis November 12, 2019 6:46 AM - StreetInsider Pfizer Announces Results of Phase 3 Study for XELJANZ® (tofacitinib) in Juvenile Idiopathic Arthritis Ahead of Presentation at 2019 American College of Rheumatology/Association of Rheumatology Profes November 12, 2019 6:45 AM - BizWire EMD Serono, Pfizer (PFE) Provide Update on Phase III JAVELIN Gastric 100 Trial November 8, 2019 8:02 AM - StreetInsider EMD Serono and Pfizer Provide Update on Phase III JAVELIN Gastric 100 Trial November 8, 2019 8:00 AM - PR NewsWire Form 10-Q PFIZER INC For: Sep 29 November 7, 2019 3:57 PM - SEC Filing Pfizer (PFE) PT Lowered to $37 at UBS November 7, 2019 5:16 AM - StreetInsider Popular stocks with increasing unusual volume: PFE YUM CVS PBR CHK November 7, 2019 4:42 AM - StreetInsider Mylan shares slide after warning of hit to revenue November 5, 2019 7:07 AM - StreetInsider Form 4 PFIZER INC For: Oct 31 Filed by: ROGERS DAWN November 1, 2019 3:57 PM - SEC Filing Form 4 PFIZER INC For: Oct 31 Filed by: YOUNG JOHN D November 1, 2019 3:57 PM - SEC Filing Form 4 PFIZER INC For: Oct 31 Filed by: JOHNSON RADY A November 1, 2019 3:56 PM - SEC Filing Form 4 PFIZER INC For: Oct 31 Filed by: BOURLA ALBERT November 1, 2019 3:56 PM - SEC Filing Form 425 PFIZER INC Filed by: PFIZER INC October 31, 2019 1:59 PM - SEC Filing Pfizer (PFE) PT Raised to $39 at Wolfe Research October 31, 2019 9:15 AM - StreetInsider Bristol-Myers posts better-than-expected results, Opdivo growth slows October 31, 2019 7:08 AM - StreetInsider Ex-FDA chief Gottlieb sees investment opportunity in 'unloved' antibiotics October 29, 2019 5:34 PM - StreetInsider SunTrust Reiterates Buy Rating on Mylan (MYL) October 29, 2019 1:01 PM - StreetInsider Pre-Open Movers 10/29: (MRTX) (AMKR) (TXRH) Higher (GRUB) (DBD) (BYND) Lower (more...) October 29, 2019 9:30 AM - StreetInsider Democratic hopeful Warren vows to bar corporate giants from hiring ex-officials October 29, 2019 9:01 AM - StreetInsider Form 8-K PFIZER INC For: Oct 29 October 29, 2019 8:55 AM - SEC Filing Wall St. dips after S&P notches record, Fed on deck October 29, 2019 7:52 AM - StreetInsider Pfizer raises 2019 forecast as sales of cancer drug, heart medicine surge October 29, 2019 7:04 AM - StreetInsider Pfizer (PFE) Tops Q3 EPS by 13c, Raises FY Guidance October 29, 2019 6:46 AM - StreetInsider PFIZER REPORTS THIRD-QUARTER 2019 RESULTS October 29, 2019 6:45 AM - BizWire Global stocks falter, dollar slips on potential U.S.-China trade delay October 28, 2019 8:44 PM - StreetInsider European Commission Approves BAVENCIO® (avelumab) Plus Axitinib Combination for First-Line Treatment of Patients With Advanced Renal Cell Carcinoma October 28, 2019 2:00 PM - PR NewsWire S&P 500 nears record high on trade progress, upbeat Intel earnings October 25, 2019 7:52 AM - StreetInsider Pre-Open 10/21: (MDR) (OPK) (FSCT) Higher (KMT) (IPHS) (BA) Lower (more...) October 21, 2019 9:21 AM - StreetInsider OPKO Health (OPK), Pfizer (PFE) announced Phase 3 trial evaluating somatrogon dosed once-weekly in pre-pubertal children with GHD met its primary endpoint October 21, 2019 8:06 AM - StreetInsider OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency October 21, 2019 8:00 AM - Globe NewsWire Form 4/A PFIZER INC For: Oct 15 Filed by: BOURLA ALBERT October 17, 2019 9:20 PM - SEC Filing Form 4 PFIZER INC For: Oct 15 Filed by: YOUNG JOHN D October 17, 2019 8:43 PM - SEC Filing Form 4 PFIZER INC For: Oct 15 Filed by: ROGERS DAWN October 17, 2019 8:43 PM - SEC Filing Form 4 PFIZER INC For: Oct 15 Filed by: JOHNSON RADY A October 17, 2019 8:43 PM - SEC Filing Form 4 PFIZER INC For: Oct 15 Filed by: BOURLA ALBERT October 17, 2019 5:02 PM - SEC Filing UPDATE: BofA/Merrill Lynch Reinstates Pfizer (PFE) at Neutral October 16, 2019 4:32 PM - StreetInsider ViiV Healthcare Submits Supplemental New Drug Application to US FDA for Use of Dovato in Virologically Suppressed Adults with HIV-1 October 16, 2019 7:00 AM - BizWire Pfizer (PFE) Reports Positive Phase 3 Data from Pivotal Study (JADE MONO-1) October 14, 2019 6:08 AM - StreetInsider ImaginAb signs multi-party collaboration agreement with three global pharmaceutical companies to help further develop company's CD8 ImmunoPET technology October 14, 2019 2:00 AM - PR NewsWire Pfizer Presents Positive Phase 3 Data at the 28th Congress of the European Academy of Dermatology and Venereology for Abrocitinib in Moderate to Severe Atopic Dermatitis October 12, 2019 4:45 AM - BizWire Form 4 PFIZER INC For: Oct 09 Filed by: YOUNG JOHN D October 10, 2019 5:41 PM - SEC Filing Form 4 PFIZER INC For: Oct 09 Filed by: ROGERS DAWN October 10, 2019 5:41 PM - SEC Filing Form 4 PFIZER INC For: Oct 09 Filed by: BOURLA ALBERT October 10, 2019 5:41 PM - SEC Filing Form 4 PFIZER INC For: Oct 09 Filed by: JOHNSON RADY A October 10, 2019 5:41 PM - SEC Filing Akcea Therapeutics (AKCA), Pfizer (PFE) Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx) October 7, 2019 6:51 AM - StreetInsider Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx) October 7, 2019 6:50 AM - Globe NewsWire Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx) October 7, 2019 6:50 AM - StreetInsider Form 4 PFIZER INC For: Sep 30 Filed by: ROGERS DAWN October 1, 2019 5:48 PM - SEC Filing Form 4 PFIZER INC For: Sep 30 Filed by: YOUNG JOHN D October 1, 2019 5:48 PM - SEC Filing Form 4 PFIZER INC For: Sep 30 Filed by: JOHNSON RADY A October 1, 2019 5:48 PM - SEC Filing Form 4 PFIZER INC For: Sep 30 Filed by: BOURLA ALBERT October 1, 2019 5:48 PM - SEC Filing Form 4 PFIZER INC For: Sep 27 Filed by: SMITH JAMES C October 1, 2019 4:20 PM - SEC Filing Form 4 PFIZER INC For: Sep 27 Filed by: KILTS JAMES M October 1, 2019 4:19 PM - SEC Filing Form 4 PFIZER INC For: Sep 27 Filed by: NARAYEN SHANTANU October 1, 2019 4:19 PM - SEC Filing Form 4 PFIZER INC For: Sep 27 Filed by: Echevarria Joseph October 1, 2019 4:19 PM - SEC Filing Checkmate Pharmaceuticals Reports Dosing of First Patient in Phase 1b/2 Study October 1, 2019 7:03 AM - StreetInsider Checkmate Pharmaceuticals Announces Dosing of First Patient in a Phase 1b/2 Study in Squamous Cell Carcinoma of the Head and Neck with Lead Investigational Candidate CMP-001 October 1, 2019 7:00 AM - BizWire Pfizer (PFE) option implied volatility low as shares near low end of range October 1, 2019 5:27 AM - StreetInsider Transgene Reports First Promising Efficacy Results with TG4001 in Combination with Avelumab in HPV-Positive Cancer at ESMO 2019 September 30, 2019 11:45 AM - BizWire Pfizer (PFE) Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI, MEKTOVI and Cetuximab for Treatment of BRAFV600E-mCRC September 30, 2019 6:22 AM - StreetInsider Pfizer Presents Interim Analysis Results from Phase 3 BEACON CRC Trial of BRAFTOVI® (Encorafenib), MEKTOVI® (Binimetinib) and Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Ca September 30, 2019 2:30 AM - BizWire Form 8-K PFIZER INC For: Sep 24 September 27, 2019 11:38 AM - SEC Filing Pfizer Inc. Awards “Golden Tickets” to Neutrolis and Mediar Therapeutics September 27, 2019 9:00 AM - BizWire Pfizer veteran Ian Read to retire as executive chairman September 27, 2019 8:18 AM - StreetInsider Pfizer (PFE) Announces Ian Read to Retire as Executive Chairman; CEO Dr. Albert Bourla Named Chairman September 27, 2019 8:02 AM - StreetInsider Ian Read to Retire as Executive Chairman of Pfizer’s Board of Directors; Chief Executive Officer Dr. Albert Bourla Named Chairman September 27, 2019 8:00 AM - BizWire Pfizer (PFE) Reports Positive Top-Line Results from Second Pivotal Phase 3 Study of Abrocitinib in Patients Aged 12 and Older with Moderate to Severe AD September 27, 2019 6:46 AM - StreetInsider Pfizer Announces Positive Top-Line Results from Second Pivotal Phase 3 Study of Investigational Oral JAK1 Candidate, Abrocitinib, in Patients Aged 12 and Older with Moderate to Severe Atopic Dermatiti September 27, 2019 6:45 AM - BizWire New Data for BAVENCIO® (avelumab) for Advanced Cancers to Be Presented at ESMO 2019 September 27, 2019 2:00 AM - PR NewsWire Pfizer (PFE) Declares $0.36 Quarterly Dividend; 4% Yield September 24, 2019 10:19 AM - StreetInsider Pfizer Declares Fourth-Quarter 2019 Dividend September 24, 2019 10:19 AM - BizWire Pfizer (PFE) Presents New Evidence of IBRANCE Effectiveness in HR+, HER2- Metastatic Breast Cancer Patients September 24, 2019 8:03 AM - StreetInsider Pfizer Presents New Evidence of IBRANCE® (palbociclib) Effectiveness in HR+, HER2- Metastatic Breast Cancer Patients in Four Real-World Studies at ESMO Congress 2019 September 24, 2019 8:00 AM - BizWire European biotech firm BioNtech plans to raise nearly $304 million in U.S. IPO September 24, 2019 7:45 AM - StreetInsider Pfizer (PFE) Gains on Open, Up 1.5% September 20, 2019 9:33 AM - StreetInsider Merck KGaA, Pfizer (PFE) Announce CHMP Adopts Positive Opinion for BAVENCIO Plus Axitinib for First-Line Treatment of Patients with Advanced RCC September 20, 2019 8:11 AM - StreetInsider CHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma September 20, 2019 8:10 AM - PR NewsWire Pfizer (PFE) Presents Scientific Advancements in Cancer Care at ESMO September 19, 2019 7:40 AM - StreetInsider Pfizer Presents Scientific Advancements in Cancer Care at the ESMO Congress 2019 Highlighting Expanded Portfolio September 19, 2019 7:38 AM - BizWire Pfizer Invites Public to View and Listen to Webcast of October 29 Conference Call With Analysts September 17, 2019 10:00 AM - BizWire Form 4 PFIZER INC For: Sep 13 Filed by: YOUNG JOHN D September 16, 2019 4:34 PM - SEC Filing Form 4 PFIZER INC For: Sep 13 Filed by: ROGERS DAWN September 16, 2019 4:34 PM - SEC Filing Form 4 PFIZER INC For: Sep 13 Filed by: JOHNSON RADY A September 16, 2019 4:34 PM - SEC Filing Form 4 PFIZER INC For: Sep 13 Filed by: BOURLA ALBERT September 16, 2019 4:34 PM - SEC Filing Form 425 PFIZER INC Filed by: PFIZER INC September 10, 2019 4:53 PM - SEC Filing UPDATE: Merck (MRK) Falls 5% on Market Open, Leading Drugmakers Lower September 10, 2019 9:34 AM - StreetInsider Pfizer (PFE) Announces Prelim. Results from Proof-of-Concept Phase 2 Study of 20-Valent Pneumococcal Conjugate Vaccine Candidate September 9, 2019 8:01 AM - StreetInsider Pfizer Announces Positive Preliminary Results from a Proof-of-Concept Phase 2 Study (B7471003) of its 20-Valent Pneumococcal Conjugate Vaccine Candidate Being Investigated for the Prevention of Invasi September 9, 2019 8:00 AM - BizWire Form 425 PFIZER INC Filed by: PFIZER INC September 4, 2019 4:39 PM - SEC Filing Form 4 PFIZER INC For: Aug 30 Filed by: Hwang Angela September 3, 2019 6:03 PM - SEC Filing Form 4 PFIZER INC For: Aug 30 Filed by: YOUNG JOHN D September 3, 2019 6:01 PM - SEC Filing Form 4 PFIZER INC For: Aug 30 Filed by: ROGERS DAWN September 3, 2019 6:01 PM - SEC Filing Form 4 PFIZER INC For: Aug 30 Filed by: JOHNSON RADY A September 3, 2019 6:01 PM - SEC Filing Form 4 PFIZER INC For: Aug 30 Filed by: BOURLA ALBERT September 3, 2019 6:01 PM - SEC Filing Pfizer (PFE) Trades Near High, Up 1.85% September 3, 2019 10:52 AM - StreetInsider Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference September 3, 2019 10:00 AM - BizWire Form 425 PFIZER INC Filed by: PFIZER INC August 30, 2019 12:38 PM - SEC Filing DZ Bank Upgrades Pfizer (PFE) to Hold August 28, 2019 5:18 AM - StreetInsider Form 4 PFIZER INC For: Aug 26 Filed by: YOUNG JOHN D August 27, 2019 11:02 AM - SEC Filing Pfizer (PFE) PT Lowered to $38 at Morgan Stanley August 27, 2019 7:57 AM - StreetInsider Form 4 PFIZER INC For: Aug 23 Filed by: Gottlieb Scott August 26, 2019 9:28 AM - SEC Filing ViiV Healthcare Announces Positive Phase III Study Results of Investigational, Long-acting, Injectable HIV-Treatment Regimen Administered Every 2 Mos. August 22, 2019 5:57 AM - StreetInsider ViiV Healthcare Reports Positive Phase III Study Results of Investigational, Long-acting, Injectable HIV-Treatment Regimen Administered Every Two Months August 22, 2019 2:17 AM - BizWire U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer August 21, 2019 2:00 PM - PR NewsWire U.S. FDA Grants XTANDI® (enzalutamide) Application Priority Review for the Treatment of Men with Metastatic Hormone-Sensitive Prostate Cancer August 21, 2019 2:00 PM - BizWire Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility in Sanford, North Carolina August 21, 2019 10:00 AM - BizWire Form 4 PFIZER INC For: Aug 19 Filed by: BOURLA ALBERT August 20, 2019 4:04 PM - SEC Filing The Pfizer Foundation Invests in 20 Organizations Tackling Infectious Diseases and Antimicrobial Resistance August 20, 2019 7:00 AM - BizWire Elanco to become No.2 in animal health with $7.6 billion Bayer deal August 20, 2019 5:59 AM - StreetInsider Full Article List